Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Teismann

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Biofactors (Oxford, England)|July 25, 2012
COX-2 in the neurodegenerative process of Parkinson's diseasePeter Teismann
International Journal of Cell Biology|July 4, 2012
Chelators in the treatment of iron accumulation in Parkinson's diseaseRoss B Mounsey, Peter Teismann
Parkinson'S Disease|January 15, 2011
Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotectionRoss B Mounsey, Peter Teismann
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2009
Glutathione--a review on its role and significance in Parkinson's diseaseHeather L Martin, Peter Teismann
Cell and Tissue Research|September 1, 2004
Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammationPeter Teismann, Jörg B Schulz
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 14, 2011
MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stressYa-Ching Hsieh, Ross B Mounsey, Peter Teismann
Annals of Neurology|April 19, 2006
Is prostaglandin E(2) a pathogenic factor in amyotrophic lateral sclerosis?Gabriele Almer, Hitoshi Kikuchi, Peter Teismann, et al.
Experimental Neurology|March 16, 2012
Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's diseaseHeather L Martin, Ross B Mounsey, Sarah Mustafa, et al.
Glia|October 30, 2015
Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's diseaseHeather L Martin, Matteo Santoro, Sarah Mustafa, et al.
Journal of Neurochemistry|October 3, 2022
Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic MPTP mouse model of Parkinson's diseaseMatteo Santoro, Paola Fadda, Katie J Klephan, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Biofactors (Oxford, England)|July 25, 2012
COX-2 in the neurodegenerative process of Parkinson's diseasePeter Teismann
International Journal of Cell Biology|July 4, 2012
Chelators in the treatment of iron accumulation in Parkinson's diseaseRoss B Mounsey, Peter Teismann
Parkinson'S Disease|January 15, 2011
Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotectionRoss B Mounsey, Peter Teismann
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2009
Glutathione--a review on its role and significance in Parkinson's diseaseHeather L Martin, Peter Teismann
Cell and Tissue Research|September 1, 2004
Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammationPeter Teismann, Jörg B Schulz
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 14, 2011
MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stressYa-Ching Hsieh, Ross B Mounsey, Peter Teismann
Annals of Neurology|April 19, 2006
Is prostaglandin E(2) a pathogenic factor in amyotrophic lateral sclerosis?Gabriele Almer, Hitoshi Kikuchi, Peter Teismann, et al.
Experimental Neurology|March 16, 2012
Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's diseaseHeather L Martin, Ross B Mounsey, Sarah Mustafa, et al.
Glia|October 30, 2015
Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's diseaseHeather L Martin, Matteo Santoro, Sarah Mustafa, et al.
Journal of Neurochemistry|October 3, 2022
Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic MPTP mouse model of Parkinson's diseaseMatteo Santoro, Paola Fadda, Katie J Klephan, et al.
Pageof 4